Javascript must be enabled to continue!
Akkermansia muciniphila secretome promotes α-synuclein aggregation in enteroendocrine cells
View through CrossRef
ABSTRACT
The notion that the gut microbiota play a role in neurodevelopment, behavior and outcome of neurodegenerative disorders is recently taking place. A number of studies have consistently reported a greater abundance of
Akkermansia muciniphila
in Parkinson’s disease (PD) fecal samples. Nevertheless, a functional link between
A.muciniphila
and sporadic PD remained unexplored. Here, we investigated whether
A.muciniphila
secretome could initiate the misfolding process of α-synuclein (αSyn) in enteroendocrine cells (EECs), which are part of the gut epithelium and possess many neuron-like properties. We found that
A
.
muciniphila
secretome is directly modulated by mucin, induces intracellular calcium (Ca
2+
) release, and causes increased mitochondrial Ca
2+
uptake in EECs, which in turn leads to production of reactive oxygen species (ROS) and αSyn aggregation. However, these events were efficiently inhibited once we buffered mitochondrial Ca
2+
. Thereby, these molecular insights provided here offer evidence that bacterial secretome is capable of inducing αSyn aggregation in enteroendocrine cells.
SYNOPSIS FIGURE DESCRIPTION
The secretome isolated from the commensal gut bacterium
Akkermansia muciniphila
triggers intracellular Ca
2+
signaling in enteroendocrine cells, leading to increased mitochondrial Ca
2+
uptake. Mitochondrial Ca
2+
overload leads to ROS generation culminating with αSyn phosphorylation and aggregation (left panel). All these events were inhibited once mitochondrial Ca
2+
is buffered (right panel).
Gram-negative gut bacterium
Akkermansia muciniphila
is consistently found more abundant in Parkinson’s disease patients.
Akkermansia muciniphila
protein secretome composition is directly modulated by mucin and induces an IP
3
-independent endoplasmic reticulum (ER)-calcium release in enteroendocrine cells.
This Ca
2+
release is triggered by direct activation of Ryanodine Receptors leading to increased mitochondrial Ca
2+
uptake.
Mitochondrial Ca
2+
overload leads to ROS generation culminating with αSyn aggregation.
Buffering mitochondrial Ca
2+
efficiently inhibits
A.muciniphila-
induced αSyn aggregation in enteroendocrine cells.
Title: Akkermansia muciniphila
secretome promotes α-synuclein aggregation in enteroendocrine cells
Description:
ABSTRACT
The notion that the gut microbiota play a role in neurodevelopment, behavior and outcome of neurodegenerative disorders is recently taking place.
A number of studies have consistently reported a greater abundance of
Akkermansia muciniphila
in Parkinson’s disease (PD) fecal samples.
Nevertheless, a functional link between
A.
muciniphila
and sporadic PD remained unexplored.
Here, we investigated whether
A.
muciniphila
secretome could initiate the misfolding process of α-synuclein (αSyn) in enteroendocrine cells (EECs), which are part of the gut epithelium and possess many neuron-like properties.
We found that
A
.
muciniphila
secretome is directly modulated by mucin, induces intracellular calcium (Ca
2+
) release, and causes increased mitochondrial Ca
2+
uptake in EECs, which in turn leads to production of reactive oxygen species (ROS) and αSyn aggregation.
However, these events were efficiently inhibited once we buffered mitochondrial Ca
2+
.
Thereby, these molecular insights provided here offer evidence that bacterial secretome is capable of inducing αSyn aggregation in enteroendocrine cells.
SYNOPSIS FIGURE DESCRIPTION
The secretome isolated from the commensal gut bacterium
Akkermansia muciniphila
triggers intracellular Ca
2+
signaling in enteroendocrine cells, leading to increased mitochondrial Ca
2+
uptake.
Mitochondrial Ca
2+
overload leads to ROS generation culminating with αSyn phosphorylation and aggregation (left panel).
All these events were inhibited once mitochondrial Ca
2+
is buffered (right panel).
Gram-negative gut bacterium
Akkermansia muciniphila
is consistently found more abundant in Parkinson’s disease patients.
Akkermansia muciniphila
protein secretome composition is directly modulated by mucin and induces an IP
3
-independent endoplasmic reticulum (ER)-calcium release in enteroendocrine cells.
This Ca
2+
release is triggered by direct activation of Ryanodine Receptors leading to increased mitochondrial Ca
2+
uptake.
Mitochondrial Ca
2+
overload leads to ROS generation culminating with αSyn aggregation.
Buffering mitochondrial Ca
2+
efficiently inhibits
A.
muciniphila-
induced αSyn aggregation in enteroendocrine cells.
Related Results
Akkermansia muciniphila: A next-generation gut probiotic supporting neurorepair and functional recovery
Akkermansia muciniphila: A next-generation gut probiotic supporting neurorepair and functional recovery
Abstract
The brain–gut axis is a bidirectional signal transduction system between the gastrointestinal tract and the central nervous system that integrates neural, endocr...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Preliminary Evaluation of the Safety and Probiotic Potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG
Preliminary Evaluation of the Safety and Probiotic Potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG
In this study, for the first time, we examined some of the physico-chemical properties of the cell surface of Akkermansia muciniphila DSM 22959, comparing it with those of Lactobac...
Growth inhibition of Akkermansia muciniphila by a secreted pathobiont sialidase
Growth inhibition of Akkermansia muciniphila by a secreted pathobiont sialidase
AbstractAkkermansia muciniphila is considered a key constituent of a healthy gut microbiota. In inflammatory bowel disease (IBD), A. muciniphila has a reduced abundance while other...
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the mo...
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
AbstractAccumulation of α-synuclein aggregates in the substantia nigra pars compacta is central in the pathophysiology of Parkinson’s disease, leading to the degeneration of dopami...
Zinc and Cobalt exposure influence
Akkermansia muciniphila
growth and short-chain fatty acid metabolism
Zinc and Cobalt exposure influence
Akkermansia muciniphila
growth and short-chain fatty acid metabolism
ABSTRACT
Akkermansia muciniphila
is a probiotic bacterium that has been proposed as a potential intervention for depression.
...
Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review
Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review
The anaerobic bacterium Akkermansia muciniphila has demonstrated its role in regulating metabolism and markers of inflammation since its discovery. It is a Gram-negative bacteria t...

